Home Cart Sign in  
Chemical Structure| 210353-53-0 Chemical Structure| 210353-53-0

Structure of Gemifloxacin Mesylate
CAS No.: 210353-53-0

Chemical Structure| 210353-53-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Gemifloxacin mesylate is an oral broad-spectrum quinolone antibacterial agent, used in the treatment of acute bacterial exacerbation of chronic bronchitis, and mild-to-moderate pneumonia.

Synonyms: LB-20304a; SB-265805S; Gemifloxacin (mesylate)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Gemifloxacin Mesylate

CAS No. :210353-53-0
Formula : C19H24FN5O7S
M.W : 485.49
SMILES Code : O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4CC(CN)/C(C4)=N/OC)=N3)C1=O)O.CS(=O)(O)=O
Synonyms :
LB-20304a; SB-265805S; Gemifloxacin (mesylate)
MDL No. :MFCD08277637

Safety of Gemifloxacin Mesylate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H341-H361-H373
Precautionary Statements:P201-P202-P260-P280-P308+P313-P405-P501

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03535558 - Recruiting December 31, 2018 United States, New Jersey ... More >> Janssen Investigative Site Recruiting Titusville, New Jersey, United States, 08560 Less <<
NCT03479736 - Completed - United States, New Jersey ... More >> Janssen Investigative Site Titusville, New Jersey, United States, 08560 Less <<
NCT01881438 - Completed - -
NCT00926796 Gonorrhoea Phase 4 Completed - United States, Alabama ... More >> University of Alabama Hospital - Infectious Diseases Birmingham, Alabama, United States, 35249-0001 United States, California Los Angeles County Department of Public Health - Sexually Transmitted Disease Program Los Angeles, California, United States, 90007-2608 San Francisco Department of Public Health - San Francisco City Clinic San Francisco, California, United States, 94103-4030 United States, Maryland Johns Hopkins Bayview Medical Center - Infectious Diseases Baltimore, Maryland, United States, 21224-2735 United States, Pennsylvania Magee Women's Hospital of UPMC - Reproductive Infectious Disease Research Pittsburgh, Pennsylvania, United States, 15213-3108 Less <<
NCT00926796 - Completed - -
NCT03326050 Rhinoscleroma Early Phase 1 Not yet recruiting October 2018 Egypt ... More >> Asmaa Ahmed Enrolling by invitation Assiut, Egypt Less <<
NCT01879007 Infectious Diseases Phase 1 Completed - Korea, Republic of ... More >> Asan medical center Seoul, Korea, Republic of Less <<
NCT02368470 Helicobacter Pylori Infection Phase 3 Unknown October 2015 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Hyuk Lee, MD Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.06mL

0.41mL

0.21mL

10.30mL

2.06mL

1.03mL

20.60mL

4.12mL

2.06mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories